Literature DB >> 14690592

Evidence that structural rearrangements and/or flexibility during TCR binding can contribute to T cell activation.

Michelle Krogsgaard1, Nelida Prado, Erin J Adams, Xiao-lin He, Dar-Chone Chow, Darcy B Wilson, K Christopher Garcia, Mark M Davis.   

Abstract

While in many cases the half-life of T cell receptor (TCR) binding to a particular ligand is a good predictor of activation potential, numerous exceptions suggest that other physical parameter(s) must also play a role. Accordingly, we analyzed the thermodynamics of TCR binding to a series of peptide-MHC ligands, three of which are more stimulatory than their stability of binding would predict. Strikingly, we find that during TCR binding these outliers show anomalously large changes in heat capacity, an indicator of conformational change or flexibility in a binding interaction. By combining the values for heat capacity (DeltaCp) and the half-life of TCR binding (t(1/2)), we find that we can accurately predict the degree of T cell stimulation. Structural analysis shows significant changes in the central TCR contact residue of the peptide-MHC, indicating that structural rearrangements within the TCR-peptide-MHC interface can contribute to T cell activation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14690592     DOI: 10.1016/s1097-2765(03)00474-x

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  111 in total

Review 1.  Mediation of T-cell activation by actin meshworks.

Authors:  Peter Beemiller; Matthew F Krummel
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-08-11       Impact factor: 10.005

2.  Fast on-rates allow short dwell time ligands to activate T cells.

Authors:  Christopher C Govern; Michelle K Paczosa; Arup K Chakraborty; Eric S Huseby
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-26       Impact factor: 11.205

Review 3.  Regulation of CD4 T-cell receptor diversity by vaccine adjuvants.

Authors:  Christina K Baumgartner; Laurent P Malherbe
Journal:  Immunology       Date:  2010-03-17       Impact factor: 7.397

4.  Structural and thermodynamic analysis of the GFP:GFP-nanobody complex.

Authors:  Marta H Kubala; Oleksiy Kovtun; Kirill Alexandrov; Brett M Collins
Journal:  Protein Sci       Date:  2010-12       Impact factor: 6.725

5.  Structural basis of semaphorin-plexin recognition and viral mimicry from Sema7A and A39R complexes with PlexinC1.

Authors:  Heli Liu; Z Sean Juo; Ann Hye-Ryong Shim; Pamela J Focia; Xiaoyan Chen; K Christopher Garcia; Xiaolin He
Journal:  Cell       Date:  2010-08-19       Impact factor: 41.582

6.  High-affinity T cell receptor differentiates cognate peptide-MHC and altered peptide ligands with distinct kinetics and thermodynamics.

Authors:  Stephen P Persaud; David L Donermeyer; K Scott Weber; David M Kranz; Paul M Allen
Journal:  Mol Immunol       Date:  2010-03-23       Impact factor: 4.407

7.  Mapping the stochastic sequence of individual ligand-receptor binding events to cellular activation: T cells act on the rare events.

Authors:  Jenny J Y Lin; Shalini T Low-Nam; Katherine N Alfieri; Darren B McAffee; Nicole C Fay; Jay T Groves
Journal:  Sci Signal       Date:  2019-01-15       Impact factor: 8.192

8.  Activation of leukemia-associated RhoGEF by Galpha13 with significant conformational rearrangements in the interface.

Authors:  Nobuchika Suzuki; Kouhei Tsumoto; Nicole Hajicek; Kenji Daigo; Reiko Tokita; Shiro Minami; Tatsuhiko Kodama; Takao Hamakubo; Tohru Kozasa
Journal:  J Biol Chem       Date:  2008-12-12       Impact factor: 5.157

9.  Peptide-MHC class II complex stability governs CD4 T cell clonal selection.

Authors:  Christina K Baumgartner; Andrea Ferrante; Mika Nagaoka; Jack Gorski; Laurent P Malherbe
Journal:  J Immunol       Date:  2009-12-09       Impact factor: 5.422

Review 10.  Organization of proximal signal initiation at the TCR:CD3 complex.

Authors:  Clifford S Guy; Dario A A Vignali
Journal:  Immunol Rev       Date:  2009-11       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.